Latest Asx Suspensions News

Page 3 of 25
Kelly Partners Group Holdings has secured conditional ASX approval to delist, clearing a regulatory milestone in its proposed move to Nasdaq. The plan still depends on shareholder approval and the US listing process, with no effective delisting date set.
Claire Turing
Claire Turing
15 Oct 2026
SIV Capital reported a $28,000 operating cash outflow for the September quarter and held $7.781 million in cash and interest-bearing deposits. The balance sheet remains substantial, but the company’s securities have now been suspended from ASX quotation since December 2024 while it evaluates a transaction.
Victor Sage
Victor Sage
14 Oct 2026
Yowie Group’s FY26 loss narrowed sharply after cost reductions and a non-cash loan impairment reversal, but revenue fell 27% and operating cash flow turned deeply negative. The confectionery maker remains loss-making, has negative net assets and faces uncertainty over funding, supply and the return of its ASX quotation.
Victor Sage
Victor Sage
6 Oct 2026
ASX has immediately suspended quotation of Antilles Gold’s AAUOD securities pending compliance with Listing Rule 2.5. The notice does not disclose the underlying compliance issue or indicate when quotation may resume.
Victor Sage
Victor Sage
2 Oct 2026
Metrics Real Estate Multi-Strategy Fund units will remain suspended on ASX after the fund failed to lodge its audited financial statements. Reinstatement now depends on the accounts being filed and ASX deciding that trading can resume appropriately.
Claire Turing
Claire Turing
1 Oct 2026
ASX will keep Metrics Master Income Trust securities suspended after the trust failed to lodge its audited financial statements. Trading will not resume until the accounts are filed and ASX considers reinstatement appropriate.
Claire Turing
Claire Turing
1 Oct 2026
Chimeric Therapeutics remains suspended from ASX trading after failing to lodge its FY2026 financial statements, with the company reporting an approximate $7.7 million net asset deficiency and unresolved creditor negotiations. Potential recapitalisation interest has emerged, but no binding funding or settlement agreement has been reached.
Ada Torres
Ada Torres
1 Oct 2026
MCS Services has completed the sale of its Traffic Business and now has no operating business, while its ASX securities remain suspended pending a possible recompliance transaction. The company reported $1.77 million in cash at 30 June 2026, but also faces a $495,000 legal settlement and no recurring operating revenue.
Victor Sage
Victor Sage
30 Sept 2026
xReality Group’s securities have been suspended from quotation after the company could not release its revised FY26 4E results while its annual accounts remain unaudited. The suspension is expected to continue until the audit is complete and the revised results and accounts are lodged.
Sophie Babbage
Sophie Babbage
30 Sept 2026
TerraCom has been suspended from trading while it completes audited FY2026 results expected to include material impairments to its South African and Australian assets. The company has not yet disclosed the size or effect of those write-downs.
Maxwell Dee
Maxwell Dee
30 Sept 2026
Paradigm Biopharmaceuticals has entered voluntary administration after its pivotal Phase 3 trial produced an interim efficacy result below the threshold required for continuation. The company’s securities will remain suspended while administrators assess its viability, liabilities and possible restructuring options.
Ada Torres
Ada Torres
30 Sept 2026
Metrics Income Opportunities Trust has been suspended from trading after its responsible entity warned that the audited FY2026 financial report may differ materially from figures released in August. The final report is expected on 30 September, but the filing does not disclose the size or direction of the changes.
Claire Turing
Claire Turing
28 Sept 2026

Browse the archive

Full archive